Global Cortical Atrophy Is Associated with an Unfavorable Outcome in Stroke Patients on Oral Anticoagulation.

Publication

Global Cortical Atrophy Is Associated with an Unfavorable Outcome in Stroke Patients on Oral Anticoagulation.

Journal Paper/Review - Dec 13, 2022

Kubacka Marta, Zietz Annaelle, Schaedelin Sabine A, Polymeris Alexandros A, Hert Lisa, Lieb Johanna Maria, Wagner Benjamin, Seiffge David Julian, Traenka Christopher, Altersberger Valerian L, Dittrich Tolga, Fladt Joachim, Fisch Urs, Thilemann Sebastian, De Marchis Gian Marco, Gensicke Henrik, Bonati Leo H, Lyrer Philippe A, Engelter Stefan T, Peters Nils

Citation

Kubacka M, Zietz A, Schaedelin S, Polymeris A, Hert L, Lieb J, Wagner B, Seiffge D, Traenka C, Altersberger V, Dittrich T, Fladt J, Fisch U, Thilemann S, De Marchis G, Gensicke H, Bonati L, Lyrer P, Engelter S, Peters N. Global Cortical Atrophy Is Associated with an Unfavorable Outcome in Stroke Patients on Oral Anticoagulation. Cerebrovasc Dis 2022:1-8.

Type

Journal Paper/Review (English)

Journal

Cerebrovasc Dis 2022

Publication Date

Dec 13, 2022

Issn Electronic

1421-9786

Pages

1-8

Brief description/objective

Measures of cerebral small vessel disease (cSVD), such as white matter hyperintensities (WMH) and cerebral microbleeds (CMB), are associated with an unfavorable clinical course in stroke patients on oral anticoagulation (OAC) for atrial fibrillation (AF). Here, we investigated whether similar findings can be observed for global cortical atrophy (GCA).